Clark & Stuart’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.44M Buy
34,841
+409
+1% +$42.7K 2.12% 18
2026
Q2
$3.12M Buy
34,432
+19,255
+127% +$1.76M 1.96% 17
2026
Q1
$1.56M Sell
15,177
-165
-1% -$18.6K 1.05% 26
2025
Q4
$1.92M Sell
15,342
-39
-0.3% -$4.97K 1.32% 23
2025
Q3
$2.06M Hold
15,381
– – 1.47% 21
2025
Q2
$2.09M Sell
15,381
-3,909
-20% -$515K 1.58% 20
2025
Q1
$2.56M Buy
19,290
+21
+0.1% +$2.67K 1.86% 20
2024
Q4
$2.18M Buy
+19,269
New +$2.23M 1.6% 22

Other funds holding ABT

Clark & Stuart's ABT Position: Q3 2026 in Review

Clark & Stuart increased its Abbott (ABT) stake by 1.2% in Q3 2026, buying an estimated $42.7K and bringing the position to 34,841 shares worth $3.44M. The position accounts for 2.12% of the portfolio, ranked #18.

Clark & Stuart first reported a position in ABT in Q4 2024 and has held it in 8 quarters since. 2,850 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

  • Clark & Stuart held 34,841 shares of Abbott worth $3.44M as of Q3 2026.
  • Clark & Stuart bought 409 Abbott shares in Q3 2026, an estimated $42.7K.
  • Abbott made up 2.12% of Clark & Stuart's portfolio in Q3 2026, its #18 holding.
  • Clark & Stuart first reported a position in Abbott in Q4 2024 and has held it in 8 quarters since.
  • 2,850 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on Clark & Stuart's 13F filing for Q3 2026, filed 14 Oct 2026.